CASP1 and metabolic dysfunction-associated steatotic liver disease: In conclusion, our research results show that BSP-1 can improve liver injury and steatosis caused by MASLD in both in vitro and in vivo experiments, this effect may be attributed to the regulation of the pyrother-related NLRP3/caspase-1/GSDMD pathway.